The 1103 and other trails under the ANP umbrella are too important.... There is more to this story.
Wonder if ANP may be looking at legal avenues and compensation - pending details of the contractual agreement between the parties, of course....
My question is this - if you were in business would you put all your eggs in one basket? I know my answer to that question...
I like to think ANP has some counter measures in place.
IMO, the trails are too important for the pharmacy industry – just because SB is no longer interested in ANP it doesn’t mean it is the end of the road..... Like to think, we will see more development. Still here for the long term.
In relation to the ATL1103 program, page-58
Add PER (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
7.9¢ |
Change
-0.001(1.25%) |
Mkt cap ! $84.79M | |||
| Open | High | Low | Value | Volume |
| 8.1¢ | 8.2¢ | 7.9¢ | $153.8K | 1.914M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 12 | 927041 | 7.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 8.1¢ | 218878 | 1 |
View Market Depth
| Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
| PER (ASX) Chart |